Mainstay Partners appears to refer to a newly launched healthcare-focused advisory and investment firm called Mainstay Healthcare Partners, which advises and invests in high-growth healthcare services and healthtech companies and is led by experienced operator-investors Kevin M. Ban, M.D., Dave Khtikian, and Dana McNally[4][1].
High-Level Overview
- Mainstay Healthcare Partners’ mission is to “guide healthcare’s next breakthroughs” by combining strategic advisory services with aligned capital to accelerate growth in healthcare services and healthtech[4][1].
- Its investment philosophy emphasizes disciplined, insight-driven strategic investments paired with hands-on advisory support across payer, provider, medtech, and digital health sectors[4].
- Key sectors include healthcare services, medtech, digital health/healthtech, and payer/provider-facing opportunities[4][1].
- Impact on the startup ecosystem: Mainstay positions itself as a pragmatic operator-investor that fills a gap between pure capital providers and operating partners by offering go-to-market, clinical oversight, leadership design, IPO readiness, and fundraising preparation alongside capital—helping scale high-growth healthcare companies more rapidly and with better commercial and clinical alignment[4].
Origin Story
- Founding year and launch: Mainstay Healthcare Partners publicly launched in a May–June 2025 press announcement as a newly formed advisory-and-investment firm[4][1].
- Key partners: The firm’s founding partners are Kevin M. Ban, M.D. (physician executive with experience at Beth Israel Deaconess Medical Center, athenahealth, and Walgreens Boots Alliance), Dave Khtikian (healthcare investor most recently at Wellington Management), and Dana McNally (growth strategist with leadership roles at Optum and other healthcare organizations)[4].
- Evolution of focus: The founding narrative emphasizes building “the kind of partner they always looked for”—a combination of real-world operator experience, strategic insight, and aligned capital—so the firm was structured from day one to provide both advisory services and selective strategic investments to growth-stage healthcare companies[4][1].
Core Differentiators
- Dual model (advisory + strategic capital): Mainstay explicitly pairs hands-on advisory services (go-to-market, leadership design, clinical oversight, IPO readiness) with disciplined investment to offer more than just check-writing[4].
- Operator-led team: Founders bring operator and clinical leadership experience (physician executive and enterprise healthcare operators), plus institutional investing expertise—allowing domain credibility with founders and boards[4].
- Sector focus and breadth: Coverage spans payer, provider, medtech, and digital health, enabling cross-domain insights and network effects across healthcare subsectors[4].
- Practical growth focus: Services listed (commercial strategy, leadership/talent support, clinical oversight) indicate emphasis on executional support rather than only strategic signal or brand[4][1].
Role in the Broader Tech Landscape
- Trend alignment: Mainstay is riding the continuing shift toward value-based care, digital transformation in healthcare delivery, and increasing private investment into healthtech and services that improve outcomes and cost-efficiency—areas attracting capital and consolidation[4].
- Timing: With growing demand for healthcare operational expertise alongside capital (especially as startups move from product-market fit to scaling clinical and commercial operations), a firm that blends advisory and selective capital is well-timed[4].
- Market forces: Aging populations, payer/provider incentives for efficiency, and broad adoption of digital health tools create addressable markets across medtech and digital health where operator-backed capital can accelerate scale[1][4].
- Influence: By providing IPO readiness and fundraising prep in addition to operational support, Mainstay can influence which companies scale successfully and how clinical and commercial best practices propagate across the ecosystem[4].
Quick Take & Future Outlook
- Near-term: Expect Mainstay to deploy a mix of advisory engagements and selective strategic investments into growth-stage healthcare services and healthtech companies where the team’s clinical and commercial experience provides measurable lift[4].
- What will shape their journey: Outcomes-driven healthcare reimbursement trends, consolidation in provider services, regulatory shifts, and the capital markets environment for healthcare IPOs and M&A will determine where and how Mainstay invests and advises[4].
- How influence may evolve: If Mainstay demonstrates repeatable value creation via combined advisory + capital, it could become a sought-after scaling partner for healthcare founders and boards, potentially expanding into larger growth rounds or sector-specific funds while deepening clinical and payer networks[4].
Quick reminder: several other organizations use “Mainstay” in their name (Mainstay Financial Services—senior housing real estate, Mainstay Capital Management—wealth advisory, and a Mainstay Wealth Management team that was acquired by Steward Partners), so be careful to distinguish Mainstay Healthcare Partners (healthcare advisory + investing launched by Ban/Khtikian/McNally) from those unrelated firms when researching or contacting the team[2][5][3].
